Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)

HKG:8189 Revenue

Tianjin TEDA Biomedical Engineering Company had revenue of 226.41M CNY in the half year ending June 30, 2025, with 21.78% growth. This brings the company's revenue in the last twelve months to 400.32M, down -4.08% year-over-year. In the year 2024, Tianjin TEDA Biomedical Engineering Company had annual revenue of 385.48M, down -3.14%.

• Revenue (ttm): 400.32M CNY
• Revenue Growth: -4.08%
• P/S Ratio: 1.51
• Revenue / Employee: 1.54M CNY
• Employees: 260
• Market Cap: 661.51M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	385.48M	-12.52M	-3.14%
Dec 31, 2023	398.00M	-5.73M	-1.42%
Dec 31, 2022	403.73M	-72.66M	-15.25%
Dec 31, 2021	476.38M	107.03M	28.98%
Dec 31, 2020	369.36M	10.60M	2.96%